5-chloropyrazinamide has been researched along with propyl pyrazinoate in 3 studies
| Studies (5-chloropyrazinamide) | Trials (5-chloropyrazinamide) | Recent Studies (post-2010) (5-chloropyrazinamide) | Studies (propyl pyrazinoate) | Trials (propyl pyrazinoate) | Recent Studies (post-2010) (propyl pyrazinoate) |
|---|---|---|---|---|---|
| 14 | 0 | 7 | 6 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Jacobs, WR; Vilchèze, C; Welch, JT; Zimhony, O | 1 |
| Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O | 1 |
| Baughn, AD; Dillon, NA; Peterson, ND; Rosen, BC | 1 |
3 other study(ies) available for 5-chloropyrazinamide and propyl pyrazinoate
| Article | Year |
|---|---|
Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
Topics: Bacterial Proteins; Fatty Acid Synthases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Structure-Activity Relationship; Tuberculosis | 2007 |
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity | 2007 |
Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.
Topics: Antitubercular Agents; beta-Alanine; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Niacinamide; Pantetheine; Pantothenic Acid; Pyrazinamide | 2014 |